Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

Nanomedicine (Lond). 2024 Aug 7:1-4. doi: 10.1080/17435889.2024.2380241. Online ahead of print.
No abstract available

Keywords: Alzheimer's and tumor; BBB; CNS immunity; Diabetic retinopathy; blood brain barrier (BBB); cell-specific drug delivery; central nervous system; multifunctional nanoparticles; normal; peptides.

Publication types

  • Editorial